You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

ACETAZOLAMIDE SODIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Acetazolamide Sodium patents expire, and when can generic versions of Acetazolamide Sodium launch?

Acetazolamide Sodium is a drug marketed by Avet Lifesciences, Endo Operations, Hikma, Hospira, Mylan Asi, Xgen Pharms, and Zydus Pharms. and is included in seven NDAs.

The generic ingredient in ACETAZOLAMIDE SODIUM is acetazolamide sodium. There are ten drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the acetazolamide sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Acetazolamide Sodium

A generic version of ACETAZOLAMIDE SODIUM was approved as acetazolamide sodium by HIKMA on February 28th, 1995.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ACETAZOLAMIDE SODIUM?
  • What are the global sales for ACETAZOLAMIDE SODIUM?
  • What is Average Wholesale Price for ACETAZOLAMIDE SODIUM?
Drug patent expirations by year for ACETAZOLAMIDE SODIUM
Recent Clinical Trials for ACETAZOLAMIDE SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of California, San DiegoPhase 1/Phase 2
The Leona M. and Harry B. Helmsley Charitable TrustPhase 1/Phase 2
JDRFPhase 1/Phase 2

See all ACETAZOLAMIDE SODIUM clinical trials

Pharmacology for ACETAZOLAMIDE SODIUM
Anatomical Therapeutic Chemical (ATC) Classes for ACETAZOLAMIDE SODIUM

US Patents and Regulatory Information for ACETAZOLAMIDE SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Avet Lifesciences ACETAZOLAMIDE SODIUM acetazolamide sodium INJECTABLE;INJECTION 202693-001 Dec 19, 2014 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Pharms ACETAZOLAMIDE SODIUM acetazolamide sodium INJECTABLE;INJECTION 206533-001 Apr 15, 2019 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira ACETAZOLAMIDE SODIUM acetazolamide sodium INJECTABLE;INJECTION 040108-001 Oct 30, 1995 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations ACETAZOLAMIDE SODIUM acetazolamide sodium INJECTABLE;INJECTION 205358-001 Jun 20, 2017 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma ACETAZOLAMIDE SODIUM acetazolamide sodium INJECTABLE;INJECTION 040089-001 Feb 28, 1995 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Xgen Pharms ACETAZOLAMIDE SODIUM acetazolamide sodium INJECTABLE;INJECTION 040784-001 Dec 10, 2008 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan Asi ACETAZOLAMIDE SODIUM acetazolamide sodium INJECTABLE;INJECTION 200880-001 May 9, 2012 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.